Expert Review Of Anticancer Therapy

Journal Title：Expert Review Of Anticancer Therapy

Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.

Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.

Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:

Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points.

《抗癌治疗专家评论》（ISSN 1473-7140）对癌症治疗的主要趋势提供专家评估和评论，并强调新的治疗和诊断方法的表现。

内容包括肿瘤管理、新型药物、抗癌剂和化疗、生物治疗、癌症疫苗、治疗指征、生物标志物和诊断以及治疗指南。所有文章都经过严格的同行评审，该期刊对癌症治疗的决策做出了重要贡献。

每篇评论的全面报道都由独特的专家评论格式补充，并包括以下部分：

专家意见 - 对文章中呈现的数据的个人看法，对未来可能重要的发展进行讨论，以及随着进一步研究产生更详细的结果，可能变得令人兴奋的研究途径

文章重点 - 作者最关键观点的执行摘要。

Expert Review Of Anticancer Therapy创刊于2001年，由Taylor and Francis Ltd.出版商出版，收稿方向涵盖医学 - 肿瘤学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 偏慢,4-8周 ，影响因子指数2.9，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。